Relaxin: a possible future preventive therapy for cardiovascular disease in postmenopausal women and men?

By Bigazzi M.   Bani D.   Bani Sacchi T.  

Climacteric, Vol. 4, Iss. 2, 2001-06 ,pp. : 137-143

Informa Healthcare

Access to resources Recommend Favorite

Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease

By Nappi R. E.   Albani F.   Chiovato L.   Polatti F.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 112-116

Informa Healthcare

Access to resources Recommend Favorite

Breast arterial calcification is a predictive factor of cardiovascular disease in Brazilian postmenopausal women

By Ferreira J. A. S.   Pompei L. M.   Fernandes C. E.   Azevedo L. H.   Peixoto S.  

Climacteric, Vol. 12, Iss. 5, 2009-10 ,pp. : 439-444

Informa Healthcare

Access to resources Recommend Favorite

ADRB3 and PPARγ2 gene polymorphisms and their association with cardiovascular disease risk in postmenopausal women

By Lwow F.  

Climacteric, Vol. 16, Iss. 4, 2013-08 ,pp. : 473-478

Informa Healthcare

Access to resources Recommend Favorite

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

By Prelevic G.M.   Kwong P.   Byrne D.J.   Jagroop I.A.   Ginsburg J.   Mikhailidis D.P.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 945-951

Elsevier

Access to resources Recommend Favorite